Table 2.

Comparison of Telemedicine Study Participants Not Using Technology Versus Using Technology (Insulin Pump Only, Continuous Glucose Monitor Only, or Combination)

	Not using technology (N = 42)	Using technology (N = 86)	P
Age at initial telemedicine visit, years	13.2 (3.9)	12.1 (4.3)	0.152
Male gender	29 (69.0)	48 (55.8)	0.214
T1D duration at initial telemedicine visit, years	3.5 [1.8–8.4]	3.2 [1.4–7.7]	0.726
T1D duration, years	9.7 [6.8–14.5]	8.8 [6.0–13.9]	0.443
A1c at initial telemedicine visit, %	9.2 (2.3)	8.8 (1.5)	0.239
A1c at most recent telemedicine visit, %	10.4 (2.5)	9.0 (1.8)	0.002
Insurance type			0.311
Private	16 (61.5)	61 (74.4)
Medicaid	10 (38.5)	21 (25.6)
Driving distance to main clinic, km	360.3 (150.1)	398.9 (178.6)	0.229
Rural designation of primary residence	23 (54.8)	46 (53.5)	1.000
Race/ethnicity			0.002
Hispanic	6 (14.3)	3 (3.5)
Non-Hispanic black	1 (2.4)	0 (0.0)
Non-Hispanic white	25 (59.5)	71 (82.6)
Other	4 (9.5)	0 (0.0)
Unknown	6 (14.3)	12 (14.0)
Patients with CGM use before telemedicine	1 (2.5)	25 (30.9)	0.001
Patients with pump use before telemedicine	6 (14.3)	69 (80.2)	<0.001

Bold indicates p < 0.05.

N (%), mean (SD), or median [IQR].